secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2024-09-24T23:59:59+00:00
Accession:  0001493152-24-037953
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health renamed Scienture Holdings; ticker changes to SCNX on Nasdaq
--------------------------------------------------------------------------

- Name change effective September 23, 2024; new CUSIP 80880X104.
- Stock now trades on Nasdaq under ticker SCNX; old ticker MEDS discontinued.
- Prior all-stock business combination with Scienture LLC valued at $103 million.
- Executive team and board unchanged; Suren Ajjarapu remains CEO and Chairman.
- Subsidiaries include Scienture LLC (specialty pharma) and Integra Pharma Solutions (wholesale).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/0001493152-24-037953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer